Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 3,000 | 0 | 0 | 0 | 0 |
| Gross Profit | 3,000 | N/A | N/A | N/A | N/A |
| Operating Expenses | 27,795 | 24,526 | 22,683 | 22,029 | 16,827 |
| Operating Income | -24,795 | -24,526 | -22,683 | -22,029 | -16,827 |
| Other Income | 146 | 78 | 86 | 62 | 34 |
| Pre-tax Income | -24,649 | -24,448 | -22,597 | -21,967 | -16,793 |
| Net Income Continuous | -24,649 | -24,448 | -22,597 | -21,967 | -16,793 |
| Net Income | $-24,649 | $-24,448 | $-22,597 | $-21,967 | $-16,793 |
| EPS Basic Total Ops | -0.66 | -0.67 | -0.61 | -0.60 | -0.46 |
| EPS Basic Continuous Ops | -0.66 | -0.66 | -0.61 | -0.60 | -0.46 |
| EPS Diluted Total Ops | -0.66 | -0.67 | -0.61 | -0.60 | -0.46 |
| EPS Diluted Continuous Ops | -0.66 | -0.66 | -0.61 | -0.60 | -0.46 |
| EBITDA(a) | $-24,313 | $-24,234 | $-22,380 | $-21,743 | $-16,591 |